...
首页> 外文期刊>Current opinion in pediatrics >Hyperimmunoglobulin E syndromes in pediatrics.
【24h】

Hyperimmunoglobulin E syndromes in pediatrics.

机译:小儿高免疫球蛋白E综合征。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE OF REVIEW: The hyper-IgE syndromes (HIES) are primary immunodeficiencies characterized by eczema, sinopulmonary infections, and elevated serum IgE. This review discusses the clinical similarities and differences between the autosomal dominant HIES (AD-HIES) and autosomal recessive HIES (AR-HIES) forms, as well as their causative genetic and pathophysiological mechanisms. RECENT FINDINGS: Over the past 4 years, three genetic defects have been identified in HIES. Mutations in STAT3 are associated with AD-HIES, whereas mutations in DOCK8, or rarely TYK2, are associated with AR-HIES. Recent work has confirmed that measuring T helper 17 cell numbers can help predict STAT3 mutations. In AR-HIES, loss of DOCK8 expression was found to impair T cell expansion and durable-specific antibody production by B cells. These factors probably contribute to the viral skin and other infectious susceptibilities, severe allergies, and high risk of malignancies that define this disorder. SUMMARY: Establishing the molecular diagnosis of HIES is important for optimal patient management. Infections in AD-HIES are usually well controlled by antibiotics. By contrast, the viral infections in AR-HIES are difficult to manage. Their higher mortality and progressive course emphasizes the need to identify AR-HIES patients early, for consideration of potentially curative hematopoietic cell transplantation.
机译:审查目的:高IgE综合征(HIES)是原发性免疫缺陷,其特征为湿疹,肺肺感染和血清IgE升高。这篇综述讨论了常染色体显性HIES(AD-HIES)和常染色体隐性HIES(AR-HIES)形式之间的临床相似性和差异,以及它们的致病性遗传和病理生理机制。最近的发现:在过去的四年中,HIES发现了三个遗传缺陷。 STAT3的突变与AD-HIES相关,而DOCK8或很少的TYK2的突变与AR-HIES相关。最近的工作已经证实,测量T辅助17细胞的数量可以帮助预测STAT3突变。在AR-HIES中,发现DOCK8表达缺失会损害T细胞扩增和B细胞产生的持久特异性抗体。这些因素可能会导致病毒性皮肤和其他感染性易感性,严重的变态反应以及定义这种疾病的恶性肿瘤的高风险。简介:建立HIES的分子诊断对于优化患者管理至关重要。 AD-HIES中的感染通常可以通过抗生素很好地控制。相反,AR-HIES中的病毒感染难以控制。他们较高的病死率和病程进展强调需要尽早确定AR-HIES患者,以考虑可能治愈的造血细胞移植。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号